Follow
Data integrity is an important issue for pharmaceutical regulatory agencies as it ensures that data submitted to these agencies is accurate and reliable. Inaccurate or unreliable information can lead to wrong decisions about which drugs to approve or reject and lead to lawsuits.
To improve data integrity, pharmaceutical regulatory agencies need to improve their systems for verifying data submissions and ensuring accuracy of information. They also need to ensure that the data is cleaned of inaccurate or irrelevant information and that it is properly organized so that it can be analyzed effectively.
By ensuring the accuracy and reliability of information, pharmaceutical regulatory agencies can reduce the likelihood of erroneous decisions resulting from litigation. They can ensure that the best drugs are approved for use, which will benefit both patients and the economy as a whole.
